Aromatase Inhibitor-Associated Musculoskeletal Syndrome: Understanding Mechanisms and Management
Sign Up to like & getrecommendations! Published in 2021 at "Frontiers in Endocrinology"
DOI: 10.3389/fendo.2021.713700
Abstract: Aromatase inhibitors (AIs) are a key component in the chemoprevention and treatment of hormone receptor-positive (HR+) breast cancer. While the addition of AI therapy has improved cancer-related outcomes in the management of HR+ breast cancer,… read more here.
Keywords: aromatase inhibitor; musculoskeletal syndrome; inhibitor associated; management ... See more keywords